Dalian Bio-Chem Co Ltd Working Capital to Net Assets Ratio
Dalian Bio-Chem Co Ltd working capital to net assets ratio. Dalian Bio-Chem Co Ltd (603360) has a Working Capital to Net Assets ratio of 86.9% as of March 2026. Working capital of CN¥1.79 Billion (current assets of CN¥2.75 Billion minus current liabilities of CN¥960.90 Million) is measured against net assets of CN¥2.05 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check 603360 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Dalian Bio-Chem Co Ltd (2011–2025)
Working capital to net assets ratio of Dalian Bio-Chem Co Ltd from 2011 to 2025. This chart shows how Dalian Bio-Chem Co Ltd's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the ratio stands at 86.9%, reflecting working capital of CN¥1.79 Billion against net assets of CN¥2.05 Billion CNY. See Dalian Bio-Chem Co Ltd (603360) defensive interval to measure how many days the company can operate on defensive assets alone.
Dalian Bio-Chem Co Ltd Working Capital to Net Assets Ratio by Year (2011–2025)
Dalian Bio-Chem Co Ltd working capital to net assets ratio by year from 2011 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Dalian Bio-Chem Co Ltd from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Dalian Bio-Chem Co Ltd assets under control.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 84.3% | CN¥1.72 Billion | CN¥2.04 Billion | CN¥2.64 Billion | CN¥919.10 Million | ▲ +24.7 pp |
| 2024 | 59.6% | CN¥1.40 Billion | CN¥2.35 Billion | CN¥2.51 Billion | CN¥1.11 Billion | ▼ -1.4 pp |
| 2023 | 61.0% | CN¥997.63 Million | CN¥1.64 Billion | CN¥1.27 Billion | CN¥269.80 Million | ▲ +5.5 pp |
| 2022 | 55.4% | CN¥809.62 Million | CN¥1.46 Billion | CN¥1.05 Billion | CN¥240.86 Million | ▲ +37.2 pp |
| 2021 | 18.2% | CN¥190.88 Million | CN¥1.05 Billion | CN¥727.77 Million | CN¥536.89 Million | ▼ -3.6 pp |
| 2020 | 21.8% | CN¥215.47 Million | CN¥988.28 Million | CN¥611.52 Million | CN¥396.05 Million | ▼ -18.4 pp |
| 2019 | 40.2% | CN¥415.54 Million | CN¥1.03 Billion | CN¥521.80 Million | CN¥106.25 Million | ▲ +8.8 pp |
| 2018 | 31.4% | CN¥250.26 Million | CN¥798.03 Million | CN¥298.05 Million | CN¥47.79 Million | ▼ -24.5 pp |
| 2017 | 55.8% | CN¥383.34 Million | CN¥686.42 Million | CN¥425.18 Million | CN¥41.84 Million | ▲ +22.3 pp |
| 2016 | 33.5% | CN¥153.65 Million | CN¥458.09 Million | CN¥264.15 Million | CN¥110.49 Million | ▲ +21.8 pp |
| 2015 | 11.7% | CN¥42.21 Million | CN¥360.17 Million | CN¥169.32 Million | CN¥127.11 Million | ▲ +17.0 pp |
| 2014 | -5.3% | CN¥-16.11 Million | CN¥303.16 Million | CN¥182.57 Million | CN¥198.67 Million | ▼ -8.9 pp |
| 2013 | 3.6% | CN¥10.02 Million | CN¥277.14 Million | CN¥184.74 Million | CN¥174.71 Million | ▲ +14.2 pp |
| 2012 | -10.6% | CN¥-24.10 Million | CN¥228.22 Million | CN¥143.36 Million | CN¥167.46 Million | ▲ +35.6 pp |
| 2011 | -46.2% | CN¥-84.72 Million | CN¥183.41 Million | CN¥119.91 Million | CN¥204.64 Million | — |